Gene · 2053
Papers2,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Soluble Epoxide Hydrolase Inhibitors Improve Cornea Alkali Wound Healing. | FASEB J | 2026 | 41848811 | PubTator, text mining | PubMed |
| Design and synthesis of novel sEH inhibitors for the treatment of acute lung injury. | Eur J Med Chem | 2026 | 41844112 | PubTator, text mining | PubMed |
| Limonin induces ferroptosis in cervical squamous cell carcinoma by activating the expression of soluble epoxide hydrolase 2 protein. | PLoS One | 2026 | 41838669 | PubTator, text mining | PubMed |
| Identification of quinolinyl-containing dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors with moderate potency towards acetylcholinesterase. | Results Chem | 2026 | 41800329 | PubTator, text mining | PubMed |
| Gene expression-based machine learning model for diagnosis, prognosis, and treatment response prediction in hepatocellular carcinoma: a retrospective study. | J Yeungnam Med Sci | 2026 | 41787910 | PubTator, text mining | PubMed |
| Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. | Med Rev (2021) | 2026 | 41783891 | PubTator, text mining | PubMed |
| Molecular Design with Artificial Intelligence: Progress and Perspectives for Small Molecules. | Chem Rev | 2026 | 41764645 | PubTator, text mining | PubMed |
| Current Computational Approaches for the Discovery of Novel Anticancer Agents Targeting VEGFR and SIRT Signaling Pathways. | Pharmaceutics | 2026 | 41755014 | PubTator, text mining | PubMed |
| Alteplase and Angioedema: Can Clinical Exome Sequencing Redefine the Paradigm? | Life (Basel) | 2026 | 41752838 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Immune-Related Mitochondrial Genes in Ischemic Stroke Through Integrated Bioinformatics and Validation. | Biomedicines | 2026 | 41751274 | PubTator, text mining | PubMed |
| Coptidis Rhizoma Alkaloids Alleviate Acetaminophen-Induced Liver Injury by Regulating GSH Metabolism and the TNF Signaling Pathway. | Antioxidants (Basel) | 2026 | 41750604 | PubTator, text mining | PubMed |
| Sources of Oxidative Stress in Parkinson's Disease: Pathways and Therapeutic Implications. | Antioxidants (Basel) | 2026 | 41750568 | PubTator, text mining | PubMed |
| Integrative machine learning and molecular docking reveal Narirutin targets ABCC1/ABCG2 for immune microenvironment remodeling in colorectal cancer. | Sci Rep | 2026 | 41741495 | PubTator, text mining | PubMed |
| Disturbance of Oxylipin Metabolism Mediated by Autophagy of Mesenteric Adipocytes Orchestrates Gut Inflammation in Crohn's Disease. | Cell Mol Gastroenterol Hepatol | 2026 | 41740852 | PubTator, text mining | PubMed |
| A new era in targeted sEH therapy: strategic evolution from inhibition to protein degradation. | Eur J Med Chem | 2026 | 41734594 | PubTator, text mining | PubMed |
| Screening and validation of potential molecular markers for colorectal cancer: based on bioinformatics analysis and machine learning. | Clin Exp Med | 2026 | 41723787 | PubTator, text mining | PubMed |
| Direct-to-Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery. | ChemMedChem | 2026 | 41716046 | PubTator, text mining | PubMed |
| Lipid metabolism in homeostasis and disease. | Signal Transduct Target Ther | 2026 | 41692800 | PubTator, text mining | PubMed |
| Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension. | Compr Physiol | 2026 | 41652841 | PubTator, text mining | PubMed |
| PTUPB, a soluble epoxide hydrolase/cyclooxygenase‑2 dual inhibitor, reduces endothelial‑to‑mesenchymal transition and improves doxorubicin‑induced vascular and cardiac toxicity. | Mol Med Rep | 2026 | 41614417 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2053/papers?page=3